Literature DB >> 19050242

A novel ICOS-independent, but CD28- and SAP-dependent, pathway of T cell-dependent, polysaccharide-specific humoral immunity in response to intact Streptococcus pneumoniae versus pneumococcal conjugate vaccine.

Quanyi Chen1, Jennifer L Cannons, James C Paton, Hisaya Akiba, Pamela L Schwartzberg, Clifford M Snapper.   

Abstract

Polysaccharide (PS)- and protein-specific murine IgG responses to intact Streptococcus pneumoniae (Pn) are both dependent on CD4(+) T cell help, B7-dependent costimulation, and CD40/CD40 ligand interactions. However, the primary PS-specific, relative to protein-specific, IgG response terminates more rapidly, requires a shorter period of T cell help and B7-dependent costimulation, and fails to generate memory. In light of the critical role for ICOS/ICOS ligand interactions in sustaining T cell-dependent Ig responses and promoting germinal center reactions, we hypothesized that this interaction was nonessential for PS-specific IgG responses to Pn. We now demonstrate that ICOS(-/-), relative to wild-type, mice elicit a normal PS-specific IgG isotype response to Pn, despite marked inhibition of both the primary and secondary IgG anti-protein (i.e., PspA, PspC, and PsaA) response. A blocking anti-ICOS ligand mAb injected during primary Pn immunization inhibits both the primary anti-protein response and the generation of protein-specific memory, but has no effect when injected during secondary immunization. In contrast to Pn, both PS- and protein-specific IgG responses to a pneumococcal conjugate vaccine are inhibited in ICOS(-/-) mice. ICOS(-/-) mice immunized with intact Pn or conjugate exhibit nearly complete abrogation in germinal center formation. Finally, although mice that lack the adaptor molecule SAP (SLAM-associated protein) resemble ICOS(-/-) mice (and can exhibit decreased ICOS expression), we observe that the PS-specific, as well as protein-specific, IgG responses to both Pn and conjugate are markedly defective in SAP(-/-) mice. These data define a novel T cell-, SAP-, and B7-dependent, but ICOS-independent, extrafollicular pathway of Ig induction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19050242      PMCID: PMC2893027          DOI: 10.4049/jimmunol.181.12.8258

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  65 in total

Review 1.  The right place at the right time: novel B7 family members regulate effector T cell responses.

Authors:  Linda Liang; William C Sha
Journal:  Curr Opin Immunol       Date:  2002-06       Impact factor: 7.486

2.  ICOS co-stimulatory receptor is essential for T-cell activation and function.

Authors:  C Dong; A E Juedes; U A Temann; S Shresta; J P Allison; N H Ruddle; R A Flavell
Journal:  Nature       Date:  2001-01-04       Impact factor: 49.962

3.  CDw150 associates with src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis.

Authors:  S V Mikhalap; L M Shlapatska; A G Berdova; C L Law; E A Clark; S P Sidorenko
Journal:  J Immunol       Date:  1999-05-15       Impact factor: 5.422

4.  CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones.

Authors:  F A Harding; J G McArthur; J A Gross; D H Raulet; J P Allison
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

5.  Lsc regulates marginal-zone B cell migration and adhesion and is required for the IgM T-dependent antibody response.

Authors:  Anatoly Rubtsov; Pamela Strauch; Alyssa Digiacomo; Jiancheng Hu; Roberta Pelanda; Raul M Torres
Journal:  Immunity       Date:  2005-11       Impact factor: 31.745

Review 6.  Germinal-center organization and cellular dynamics.

Authors:  Christopher D C Allen; Takaharu Okada; Jason G Cyster
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

Review 7.  Molecular and cellular pathogenesis of X-linked lymphoproliferative disease.

Authors:  Kim E Nichols; Cindy S Ma; Jennifer L Cannons; Pamela L Schwartzberg; Stuart G Tangye
Journal:  Immunol Rev       Date:  2005-02       Impact factor: 12.988

8.  Effects of pH and polysaccharides on peptide binding to class II major histocompatibility complex molecules.

Authors:  C V Harding; R W Roof; P M Allen; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

9.  Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation.

Authors:  Hideyuki Iwai; Yuko Kozono; Sachiko Hirose; Hisaya Akiba; Hideo Yagita; Ko Okumura; Hitoshi Kohsaka; Nobuyuki Miyasaka; Miyuki Azuma
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

10.  Immunization of aged mice with a pneumococcal conjugate vaccine combined with an unmethylated CpG-containing oligodeoxynucleotide restores defective immunoglobulin G antipolysaccharide responses and specific CD4+-T-cell priming to young adult levels.

Authors:  Goutam Sen; Quanyi Chen; Clifford M Snapper
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

View more
  18 in total

1.  Facultative role for T cells in extrafollicular Toll-like receptor-dependent autoreactive B-cell responses in vivo.

Authors:  Rebecca A Sweet; Michelle L Ols; Jaime L Cullen; Ashley Viehmann Milam; Hideo Yagita; Mark J Shlomchik
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

2.  Germinal center T follicular helper cell IL-4 production is dependent on signaling lymphocytic activation molecule receptor (CD150).

Authors:  Isharat Yusuf; Robin Kageyama; Laurel Monticelli; Robert J Johnston; Daniel Ditoro; Kyle Hansen; Burton Barnett; Shane Crotty
Journal:  J Immunol       Date:  2010-06-04       Impact factor: 5.422

Review 3.  T follicular helper cells in space-time.

Authors:  Hai Qi
Journal:  Nat Rev Immunol       Date:  2016-08-30       Impact factor: 53.106

4.  The nature of an in vivo anti-capsular polysaccharide response is markedly influenced by the composition and/or architecture of the bacterial subcapsular domain.

Authors:  Swadhinya Arjunaraja; Paola Massari; Lee M Wetzler; Andrew Lees; Jesus Colino; Clifford M Snapper
Journal:  J Immunol       Date:  2011-12-07       Impact factor: 5.422

5.  Functional T-cell deficiency in adolescents who experience serogroup C meningococcal disease despite receiving the meningococcal serogroup C conjugate vaccine.

Authors:  Rachel A Foster; Jennifer Carlring; Andrew Lees; Ray Borrow; Mary Ramsay; Ed Kacsmarski; Elizabeth Miller; Michael W McKendrick; Andrew W Heath; Robert C Read
Journal:  Clin Vaccine Immunol       Date:  2010-05-12

6.  Noncovalent association of protein and capsular polysaccharide on bacteria-sized latex beads as a model for polysaccharide-specific humoral immunity to intact gram-positive extracellular bacteria.

Authors:  Jesus Colino; Leah Duke; Clifford M Snapper
Journal:  J Immunol       Date:  2013-08-07       Impact factor: 5.422

7.  Structurally identical capsular polysaccharide expressed by intact group B streptococcus versus Streptococcus pneumoniae elicits distinct murine polysaccharide-specific IgG responses in vivo.

Authors:  Swadhinya Arjunaraja; Lawrence C Paoletti; Clifford M Snapper
Journal:  J Immunol       Date:  2012-04-20       Impact factor: 5.422

8.  Immune response to Streptococcus pneumoniae in asthma patients: comparison between stable situation and exacerbation.

Authors:  C Otero; R D Paz; N Galassi; L Bezrodnik; M R Finiasz; S Fink
Journal:  Clin Exp Immunol       Date:  2013-07       Impact factor: 4.330

9.  Inflammatory monocytes are critical for induction of a polysaccharide-specific antibody response to an intact bacterium.

Authors:  Quanyi Chen; Clifford M Snapper
Journal:  J Immunol       Date:  2012-12-26       Impact factor: 5.422

10.  A novel tetrameric gp350 1-470 as a potential Epstein-Barr virus vaccine.

Authors:  Xinle Cui; Zhouhong Cao; Goutam Sen; Gouri Chattopadhyay; Deborah H Fuller; James T Fuller; Dustin M Snapper; Andrew L Snow; James J Mond; Clifford M Snapper
Journal:  Vaccine       Date:  2013-05-09       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.